Teladoc Health, Inc. $TDOC Shares Bought by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al grew its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 62.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 243,525 shares of the health services provider’s stock after acquiring an additional 93,450 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al owned about 0.14% of Teladoc Health worth $1,705,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. IFP Advisors Inc lifted its holdings in Teladoc Health by 412.1% in the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after purchasing an additional 3,210 shares during the period. Aster Capital Management DIFC Ltd lifted its holdings in Teladoc Health by 101.1% in the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock worth $37,000 after purchasing an additional 2,425 shares during the period. International Assets Investment Management LLC acquired a new stake in Teladoc Health in the fourth quarter worth about $45,000. Bayforest Capital Ltd acquired a new stake in Teladoc Health in the third quarter worth about $58,000. Finally, KBC Group NV lifted its holdings in Teladoc Health by 88.3% in the fourth quarter. KBC Group NV now owns 9,632 shares of the health services provider’s stock worth $67,000 after purchasing an additional 4,516 shares during the period. Institutional investors and hedge funds own 76.82% of the company’s stock.

Analysts Set New Price Targets

TDOC has been the topic of several research reports. JPMorgan Chase & Co. dropped their price target on shares of Teladoc Health from $9.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, March 13th. Bank of America upgraded shares of Teladoc Health from a “neutral” rating to a “buy” rating and set a $7.00 price target on the stock in a research report on Thursday, February 26th. BMO Capital Markets dropped their price target on shares of Teladoc Health from $8.00 to $5.00 and set a “market perform” rating on the stock in a research report on Thursday, February 26th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Teladoc Health in a research report on Friday, March 27th. Finally, Canaccord Genuity Group dropped their price target on shares of Teladoc Health from $12.00 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Five research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $7.53.

Insiders Place Their Bets

In other news, CEO Charles Divita III sold 27,731 shares of the company’s stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $5.49, for a total value of $152,243.19. Following the transaction, the chief executive officer owned 364,784 shares in the company, valued at $2,002,664.16. This represents a 7.06% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.70% of the stock is currently owned by company insiders.

Teladoc Health Price Performance

NYSE TDOC opened at $6.37 on Friday. The stock’s 50-day moving average price is $5.73 and its two-hundred day moving average price is $6.32. The company has a current ratio of 2.80, a quick ratio of 2.72 and a debt-to-equity ratio of 0.75. The company has a market cap of $1.15 billion, a PE ratio of -6.56 and a beta of 2.08. Teladoc Health, Inc. has a 1 year low of $4.40 and a 1 year high of $9.77.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.01). The company had revenue of $613.85 million for the quarter, compared to analyst estimates of $611.04 million. Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.Teladoc Health’s quarterly revenue was down 2.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.53) EPS. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. On average, analysts predict that Teladoc Health, Inc. will post -0.92 EPS for the current year.

Teladoc Health News Roundup

Here are the key news stories impacting Teladoc Health this week:

• Positive Sentiment: Zacks Research raised estimates for several near- and medium-term periods, including Q1 2028, Q2 2027, Q1 2027, Q3 2026, Q2 2026 and FY2026, suggesting slightly better expected profitability than before. BetterHelp Joins Patient Safety Organization to Advance Quality and Safety Practices in Virtual Mental Health Care
• Neutral Sentiment: BetterHelp, Teladoc’s online therapy business, joined a Patient Safety Organization to improve quality and safety in virtual mental health care, which is more of a long-term operational/brand-positive development than an immediate financial catalyst. BetterHelp Joins Patient Safety Organization to Advance Quality and Safety Practices in Virtual Mental Health Care
• Negative Sentiment: Analysts also cut estimates for some future periods, including Q4 2026, Q3 2027, Q4 2027, FY2027 and FY2028, reinforcing concerns that Teladoc may still face earnings pressure.
• Negative Sentiment: The broader context remains weak: Teladoc recently posted a quarterly EPS miss and management’s guidance still points to losses, which can weigh on investor sentiment toward TDOC.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.